Drug: |
Nilotinib or Imatinib |
|||
---|---|---|---|---|
Trial: |
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1) |
|||
Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
University of Michigan1500 East Medical Center Dr |
Principal Investigator: |
Scott Schuetze, MD |
---|---|
Contact: |
Gino Metko 734-647-2095 minom@umich.edu Rivka Siden 734-936-8210 sidenr@umich.edu |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
University of Michigan Website: |
https://www.umms.med.umich.edu/engage/disp_pub_main.do |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.